
News Center
-
Feb 12, 2026
Arctic Vision Announces Deal to Integrate MDCO Technology's Ophthalmic Device Business to Form a Global Drug–Device Innovation Platform
Arctic Vision Announces Deal to Integrate MDCO Technology
-
Feb 18, 2026
Arctic Vision Announced CDE Acceptance of New Drug Application for ARCATUS® (ARVN001) to Treat Uveitic Macular Edema (UME) in China
Arctic Vision Announces Deal to Integrate MDCO Technology
-
Jan 02, 2026
Arctic Vision Announced TGA Approval of New Drug Application for ARCATUS® (ARVN001) to Treat Uveitic Macular Edema (UME) in Australia
ARVNO01 to Treat Uveitic Macular Edema (UME) in Australia
-
Jan 02, 2026
Arctic Vision Wins the Hurun Future Unicorns Global Gazelles Index of 2024
Arctic Vision Wins the Hurun Future Unicorns Global Gazelles Index of 2024
-
Jan 05, 2026
Santen Pharmaceutical and Arctic Vision execute a commercial collaboration agreement for ARVN001, a suprachoroidal space injection therapy for the treatment of uveitic macular edema
Santen Pharmaceutical and Arctic Vision execute a commercialcollaboration agreement for...
-
Jan 20, 2026
Innovation is everywhere – Hong Kong Enterprise Innovation Project Selection and Recognition Conference came to a Successful Conclusion
Innovation is everywhere

